Literature DB >> 16571836

Hepatitis B virus particle formation in the absence of pregenomic RNA and reverse transcriptase.

Wiebke Schormann1, Anke Kraft, Dirk Ponsel, Volker Bruss.   

Abstract

Cytoplasmic hepatitis B virus (HBV) capsids are not enveloped and secreted unless the packaged RNA pregenome is reverse transcribed. The expression of the capsid protein C, together with envelope proteins in the absence of pregenomic RNA, produced normal amounts of intracellular capsids, but the secretion of virion-like particles was greatly reduced. The I97L C protein mutant, allowing immature nucleocapsid envelopment in the background of an HBV genome, did not promote the envelopment of capsids lacking a pregenome, suggesting that this mutation is not sufficient to induce secretion competence independently of the pregenome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571836      PMCID: PMC1440432          DOI: 10.1128/JVI.80.8.4187-4190.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  Intracellular hepadnavirus nucleocapsids are selected for secretion by envelope protein-independent membrane binding.

Authors:  H Mabit; H Schaller
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Duck hepatitis B virus virion secretion requires a double-stranded DNA genome.

Authors:  David Perlman; Jianming Hu
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  Hepatitis B virus core gene mutations which block nucleocapsid envelopment.

Authors:  M Koschel; D Oed; T Gerelsaikhan; R Thomssen; V Bruss
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

5.  Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids.

Authors:  David H Perlman; Eric A Berg; Peter B O'connor; Catherine E Costello; Jianming Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

6.  Crystalline aggregates of hepatitis B core particles in cytoplasm of hepatocytes.

Authors:  T Michalak; A Nowosławski
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

7.  Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis.

Authors:  T Gerelsaikhan; J E Tavis; V Bruss
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses.

Authors:  Y Wei; J E Tavis; D Ganem
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus.

Authors:  M Kann; W H Gerlich
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  The role of envelope proteins in hepatitis B virus assembly.

Authors:  V Bruss; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  19 in total

1.  Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.

Authors:  Michael Kotiw; Megan Johnson; Manisha Pandey; Scott Fry; Stuart L Hazell; Hans J Netter; Michael F Good; Colleen Olive
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

2.  Alkylated porphyrins have broad antiviral activity against hepadnaviruses, flaviviruses, filoviruses, and arenaviruses.

Authors:  Haitao Guo; Xiaoben Pan; Richeng Mao; Xianchao Zhang; Lijuan Wang; Xuanyong Lu; Jinhong Chang; Ju-Tao Guo; Shendra Passic; Fred C Krebs; Brian Wigdahl; Travis K Warren; Cary J Retterer; Sina Bavari; Xiaodong Xu; Andrea Cuconati; Timothy M Block
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

3.  Inhibition of hepatitis B virus gene expression and replication by hepatocyte nuclear factor 6.

Authors:  Ruidong Hao; Jing He; Xing Liu; Guozhen Gao; Dan Liu; Lei Cui; Guojun Yu; Wenhui Yu; Yu Chen; Deyin Guo
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

4.  Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus.

Authors:  Silke Arzberger; Marianna Hösel; Ulrike Protzer
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

5.  Hepatitis B virus core protein with hot-spot mutations inhibit MxA gene transcription but has no effect on inhibition of virus replication by interferon α.

Authors:  Yu Zhijian; Huang Zhen; Zhang Fan; Yang Jin; Deng Qiwen; Zeng Zhongming
Journal:  Virol J       Date:  2010-10-20       Impact factor: 4.099

6.  Snow goose hepatitis B virus (SGHBV) envelope and capsid proteins independently contribute to the ability of SGHBV to package capsids containing single-stranded DNA in virions.

Authors:  Natalie Greco; Michael H Hayes; Daniel D Loeb
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

7.  Functional surfaces of the hepatitis B virus capsid.

Authors:  Alexander Pairan; Volker Bruss
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

8.  Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.

Authors:  Haitao Guo; Dong Jiang; Tianlun Zhou; Andrea Cuconati; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

9.  Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells.

Authors:  Haitao Guo; Dong Jiang; Dongling Ma; Jinhong Chang; Anne Marie Dougherty; Andrea Cuconati; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

Review 10.  Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection.

Authors:  Shi Liu; Bin Zhou; Juan D Valdes; Jian Sun; Haitao Guo
Journal:  Hepatology       Date:  2019-03-20       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.